Sharon Yavrom

Sharon Yavrom

Company: IMUGENE

Job title: Executive Director, Clinical Science


Overview of CF33 Vaccinia Oncolytic Virus Platform 9:30 am

Scientific review of the CF33 OV platform Clinical development overview of CF33, checkvacc (CF33-PDL1), and onCARlytic (CF33-CD19) Future development of the OV platformRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.